Dive Strategic Profile of Thermo Fisher Scientific Inc.: Scientific Leadership, Global Scale, and Transformative ...

Thermo Fisher Scientific is closing its Carlsbad DNA manufacturing site less than three years after opening it, a move that will mean the loss of more than 70 local jobs. In July 2021, Thermo Fisher ...

Thermo Fisher Scientific Inc. continues to pursue acquisitions to add to its growing portfolio. The company's current operating performance is soft, with organic sales growth coming to a standstill.

In addition to the financial measures prepared in accordance with generally accepted accounting principles (GAAP), we use certain non-GAAP financial measures such as ...

Third quarter revenue grew 5% to $11.12 billion. Third quarter GAAP diluted earnings per share (EPS) was $4.27, in-line with the prior-year quarter. Third quarter adjusted EPS grew 10% to $5.79.

For more information related to non-GAAP financial measures, refer to the section titled “Supplemental Information Regarding Non-GAAP Financial Measures” of this release. Supplemental Information ...

Thermo Fisher Scientific (TMO) just picked up fresh buy ratings on the back of its Asian bioprocessing expansion and a new cardiovascular risk testing partnership, and investors are treating that ...